AAAAAA

   
Results: 1-25 | 26-50 | 51-63 |
Results: 51-63/63
Naloxone in the prevention of the adverse cognitive effects of ECT: A within-subject, placebo controlled study
Authors: Prudic, J Fitzsimons, L Nobler, MS Sackeim, HA
Citation: J. Prudic et al., Naloxone in the prevention of the adverse cognitive effects of ECT: A within-subject, placebo controlled study, NEUROPSYCH, 21(2), 1999, pp. 285-293
Cerebral blood flow and metabolism in late-life depression and dementia
Authors: Nobler, MS Pelton, GH Sackeim, HA
Citation: Ms. Nobler et al., Cerebral blood flow and metabolism in late-life depression and dementia, J GER PSY N, 12(3), 1999, pp. 118-127
The orienting response in schizophrenia and mania
Authors: Schnur, DB Smith, S Smith, A Marte, V Horwitz, E Sackeim, HA Mukherjee, S Bernstein, AS
Citation: Db. Schnur et al., The orienting response in schizophrenia and mania, PSYCHIAT R, 88(1), 1999, pp. 41-54
Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging
Authors: Nobler, MS Mann, JJ Sackeim, HA
Citation: Ms. Nobler et al., Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging, BRAIN RES R, 30(3), 1999, pp. 250-263
The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder
Authors: Crismon, ML Trivedi, M Pigott, TA Rush, AJ Hirschfeld, RMA Kahn, DA DeBattista, C Nelson, JC Nierenberg, AA Sackeim, HA Thase, ME
Citation: Ml. Crismon et al., The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder, J CLIN PSY, 60(3), 1999, pp. 142-156
Electroconvulsive therapy and suicide risk
Authors: Prudic, J Sackeim, HA
Citation: J. Prudic et Ha. Sackeim, Electroconvulsive therapy and suicide risk, J CLIN PSY, 60, 1999, pp. 104-110
Amphetamine disrupts P50 suppression in normal subjects
Authors: Light, GA Malaspina, D Geyer, MA Luber, BM Coleman, EA Sackeim, HA Braff, DL
Citation: Ga. Light et al., Amphetamine disrupts P50 suppression in normal subjects, BIOL PSYCHI, 46(7), 1999, pp. 990-996
Prolactin response to electroconvulsive therapy - Response
Authors: Lisanby, SH Devanand, DP Prudic, J Sackeim, HA
Citation: Sh. Lisanby et al., Prolactin response to electroconvulsive therapy - Response, BIOL PSYCHI, 45(3), 1999, pp. 379-381
Transcranial magnetic stimulation - Applications in neuropsychiatry
Authors: George, MS Lisanby, SH Sackeim, HA
Citation: Ms. George et al., Transcranial magnetic stimulation - Applications in neuropsychiatry, ARCH G PSYC, 56(4), 1999, pp. 300-311
Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior
Authors: Oquendo, MA Malone, KM Ellis, SP Sackeim, HA Mann, JJ
Citation: Ma. Oquendo et al., Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior, AM J PSYCHI, 156(2), 1999, pp. 190-194
Acute efficacy of ECT in the treatment of major depression in the old-old
Authors: Tew, JD Mulsant, BH Haskett, RF Prudic, J Thase, ME Crowe, RR Dolata, D Begley, AE Reynolds, CF Sackeim, HA
Citation: Jd. Tew et al., Acute efficacy of ECT in the treatment of major depression in the old-old, AM J PSYCHI, 156(12), 1999, pp. 1865-1870
The relative efficiency of altering pulse frequency or train duration whendetermining seizure threshold
Authors: Devanand, DP Lisanby, SH Nobler, MS Sackeim, HA
Citation: Dp. Devanand et al., The relative efficiency of altering pulse frequency or train duration whendetermining seizure threshold, J ECT, 14(4), 1998, pp. 227-235
Theophylline and ECT
Authors: Fink, M Sackeim, HA
Citation: M. Fink et Ha. Sackeim, Theophylline and ECT, J ECT, 14(4), 1998, pp. 286-290
Risultati: 1-25 | 26-50 | 51-63 |